Shawn McCormick - Inspire Medical Independent Director
| INSP Stock | USD 157.79 1.35 0.86% |
Director
Mr. Shawn T. McCormick serves as Independent Director of the Company since January 2017. Mr. McCormick served as Chief Financial Officer of Tornier N.V., a global orthopedic company, from September 2012 until October 2015 when Tornier merged with Wright Medical Group, Inc. Before Tornier, Mr. McCormick served as Chief Operating Officer of Lutonix, Inc., a medical device company, from April 2011 to February 2012, and as Chief Financial Officer and Senior Vice President of ev3 Inc., a global endovascular company, from January 2009 to July 2010, when ev3 was acquired by Covidien plc. From 2002 to 2009, Mr. McCormick held various positions at Medtronic, including as its Vice President, Corporationrationrate Development, where he was responsible for leading Medtronics worldwide business development activities. In addition to serving on our Board of Directors, Mr. McCormick has served on the board of directors of Nevro Corporationration since September 2014 and Surmodics, Inc. since December 2015. Mr. McCormick also served on the board of directors of Entellus Medical, Inc. from November 2014 to February 2018 since 2017.
| Age | 56 |
| Tenure | 7 years |
| Professional Marks | MBA |
| Address | 5500 Wayzata Blvd., Golden Valley, MN, United States, 55416 |
| Phone | 844 672 4357 |
| Web | https://www.inspiresleep.com |
Shawn McCormick Latest Insider Activity
Tracking and analyzing the buying and selling activities of Shawn McCormick against Inspire Medical stock is an integral part of due diligence when investing in Inspire Medical. Shawn McCormick insider activity provides valuable insight into whether Inspire Medical is net buyers or sellers over its current business cycle. Note, Inspire Medical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Inspire Medical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Shawn McCormick over a month ago Acquisition by Shawn McCormick of 716 shares of Inspire Medical subject to Rule 16b-3 |
Inspire Medical Management Efficiency
The company has return on total asset (ROA) of (0.0358) % which means that it has lost $0.0358 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0288) %, meaning that it created substantial loss on money invested by shareholders. Inspire Medical's management efficiency ratios could be used to measure how well Inspire Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of 06/09/2024, Return On Tangible Assets is likely to drop to -0.03. In addition to that, Return On Capital Employed is likely to drop to -0.07. At this time, Inspire Medical's Total Current Liabilities is relatively stable compared to the past year. As of 06/09/2024, Liabilities And Stockholders Equity is likely to grow to about 710.7 M, while Non Current Liabilities Total is likely to drop slightly above 23.1 M.Management Performance
| Return On Equity | -0.0288 | ||||
| Return On Asset | -0.0358 |
Inspire Medical Systems Leadership Team
Elected by the shareholders, the Inspire Medical's board of directors comprises two types of representatives: Inspire Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Inspire. The board's role is to monitor Inspire Medical's management team and ensure that shareholders' interests are well served. Inspire Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Inspire Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Georgia GarinoisMelenikiotou, Independent Director | ||
| Megan CPA, Director Reporting | ||
| Timothy Herbert, President, Chief Executive Officer, Director | ||
| Steven Jandrich, Chief Compliance Officer, Vice President of Human Resources | ||
| Philip Ebeling, Chief Operating Officer | ||
| Ezgi Yagci, Vice Relations | ||
| Andreas Henke, Senior Europe | ||
| Casey Tansey, Independent Director | ||
| Richard Buchholz, Chief Financial Officer | ||
| Kathy Sherwood, Senior Access | ||
| Martin Abrams, Vice Experience | ||
| Gary Ellis, Independent Director | ||
| John Rondoni, Chief Officer | ||
| Shawn McCormick, Independent Director | ||
| Carlton Weatherby, Chief Officer | ||
| Randall Ban, Senior Vice President Global Sales and Marketing | ||
| Dana Mead, Independent Director | ||
| Shelley Broader, Independent Director | ||
| Ivan Lubogo, Senior Sales | ||
| Georgia Melenikiotou, Independent Director | ||
| MD FAAOS, Chief Officer | ||
| Marilyn Nelson, Independent Chairman of the Board | ||
| Jerry Griffin, Independent Director | ||
| Bryan Phillips, Senior Vice President Chief Compliance Officer, General Counsel, Company Secretary |
Inspire Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Inspire Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0288 | ||||
| Return On Asset | -0.0358 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 4.27 B | ||||
| Shares Outstanding | 29.71 M | ||||
| Shares Owned By Insiders | 1.98 % | ||||
| Shares Owned By Institutions | 98.02 % | ||||
| Number Of Shares Shorted | 1.85 M | ||||
| Price To Earning | 15.29 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Tools for Inspire Stock Analysis
When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.